Dr. Sateesh Belemkar

Qualification              : M. Pharm., Ph.D.

Specialization             : Pharmacology & Toxicology

E mail                         : Sateesh.b@nmims.edu

Phone                         : 022-42332000 (Extn- 2017)

Experience                 : 25 years (Academics)

Dr Sateesh Belemkar studied B Pharm (1994, Gulbarga University), M Pharm (1997, Karnatak University) and Ph.D (2010, NMIMS University) from reputed Institutions. He is having vast experience in teaching subjects of Anatomy & Physiology, Pathophysiology and Pharmacology & Toxicology to UG & PG. He is having expertise in handling Industrial toxicity projects and associated with pharmaceutical industries as consultant. He has conducted clinical study of antidiabetic formulations as a part of Ph D studies & registered with CTRI. He is a CCSEA nominated member and actively involved in IAEC activities. He presented research papers at APPS conference held in Los Angeles in 2009 & BIT’s conference held in Beijing China in 2012, received travel grants from DST & ICMR. He has received many awards and accolades for his research presentations.

Interest areas:

Diabetes, Toxicology and Inflammation.

Research

• Publications – 63 (International- 45, National-18)
• Book Chapters- 3
• Patents- 2
• Presentations- 47 (International- 35, National- 12)
• Industry projects
  • Completed
    • Toxicity study of NCEs, Ajanta Pharma Ltd, Mumbai amount in Rs.55 Lakhs.
    • Toxicity study of 6 new drug formulations of Lupin Ltd, Mumbai, project fund Rs.3.5 Lakhs.
• Ongoing
  • Size reduction and Patient compliance studies of a nutraceutical formulation, Septalyst Life Sciences Pvt Ltd, amount in Rs.7.5 Lakhs.
  • Evaluation of Novel formulation in experimental animals, Amaterasu Life Sciences Pvt Ltd, Mumbai, project fund 0.75 lakhs.
  • Safety & efficacy study of herbal formulations of Lupin Ltd Mumbai, project fund Rs. 0.73 lakhs

Conferences/Workshops/Seminars attended- 21

Academic activities

He has guided 45 number of M.Pharm. students for their research projects.

He has guided two candidates of PhDs successfully and two candidates are registered under his supervision. 

• Awarded 1st prize for scientific poster presentation on Modulatory effect of Lagenaria sicenaria fruit extract on prediabetic condition in Wistar rats in PCI sponsored Natioanal seminar held in Aurobindo Institute of Pharmacy Indore on 15th Feb 2020.
• Awarded 2nd prize for scientific poster presentation on Study of Glycyrrhiza glabra on glucose uptake mechanism in rats in IPA Convention Indore 2011.

Professional Memberships

• Life member of Indian Pharmaceutical Association (IPA)
• Life member of Association of Pharmaceutical teachers of India (APTI)
• Life member of Pharmacological Society of India (IPSCON)
• Member, Board of Studies, SVKM’s NMIMS, Mumbai.

Recent Publications

1. Roopali Agrawal, Sateesh Belemkar, C Bonde. A New Strategy for the Software-Assisted LC Separations of Ketoconazole and Its Impurities. Journal of Chromatographic Science, 2022. Impact factor : 1.618.

2. Harun Patel, Rahul Pawara, Iqrar Ahmad, Deepika Nayak, Sateesh Belamkar, Sanjay Surana. Design and Synthesis of the Novel, Selective WZ4002 analogue as EGFR-L858R/T790M Tyrosine Kinase Inhibitors for Targeted Drug Therapy in Non-Small-Cell Lung Cancer (NSCLC). Journal of Molecular Structure 1254, 2022. Impact factor : 3.196.

3. Harun Patel Rahul Pawara, Iqrar Ahmad, Deepika Nayak, Shivani Wagh, Avinash Wadkar, Azim Ansari, Sateesh Belamkar, Sanjay Surana,Chanakya Nath Kundu, Chandragauda Patil. Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-Small-Cell lung cancer (NSCLC). Bioorganic Chemistry, 2021. Impact factor : 5.307.

4. Aryman Girish Patwardhan, Sateesh Belemkar. Immunotherapeutic agents, stem cell therapy and gene editing. Life sciences, 282; 2021. Impact factor : 6.78.